A new preclinical study by Mass Eye and Ear investigators showed that a novel mRNA-based therapy may be able to prevent blindness and scarring from proliferative vitreoretinopathy (PVR) following a ...
Please provide your email address to receive an email when new articles are posted on . Patients with epiretinal membrane after proliferative vitreoretinopathy repair may benefit from early peeling, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback